Disease-Modifying Targets and Strategies for Alzheimer's Disease and Parkinson's Disease

  • 6,943

    Total downloads

  • 24k

    Total views and downloads

Submit your idea

Select the journal/section where you want your idea to be submitted:

Submit your manuscript summarySubmit your manuscript

About this Research Topic

Submission closed

Background

As life expectancy increases, more and more people suffer from neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), etc. One of the significant challenges for these diseases is finding reliable disease-modifying treatments, which can postpone or reverse the progression of the disease. Although we have accumulated a large amount of research into understanding neurodegenerative diseases over decades, the exact disease-modifying targets and valuable strategies still need to be developed.

To date, the primary treatment for neurodegenerative diseases is to alleviate symptoms. For AD, one fantastic piece of news is the recent success of the anti-Aβ antibody treatment for Alzheimer's disease (AD). Although it was reported that the antibody aducanumab cleared Aβ plaques from the prodromal or mild AD brains and slowed the cognitive decline of many patients, suggesting its potential disease-modifying effect, more evidence should be provided to verify these results. For PD, levodopa is the best medication to improve motor symptoms. However, prolonged treatment with levodopa will bring side effects, such as fluctuant symptoms, dyskinesia, etc. Moreover, symptoms will continue to deteriorate and be less responsive or even not responsive to the drugs in the end. In the past decades, several promising agents for PD have advanced into clinical trials, including targeting PD risk genes (leucine-rich repeat kinase 2 (LRRK2), glucocerebrosidase (GBA), α-Synuclein), or slowing the dysfunctional cell biology progression of PD (the synapse vesicle trafficking, microtubule motor, inflammation, oxidative stress, mitochondrial function, etc.). Although some drugs showed exciting results in phase 1 or 2 of clinical trials, they all failed to meet primary endpoints in the end. At the same time, non-pharmacological interventions also draw significant attention, such as immune therapy, gene therapy, stem cell transplantation, and hyperbaric oxygen therapy. Still, none has reached the goal of modifying the disease. The major impediment is the lack of specific targets that can halt the progression of the disease. Aiming to modify the disorders, the pathogenesis and pathological features of the conditions should be fully elucidated.

Here, we call for excellent research on exploring specific disease-modifying targets and developing advancing disease-modifying strategies for the two prevalent neurodegenerative diseases, AD and PD.

This Research Topic only accepts Original Research and Systematic Review.

The potential topics focus on, but are not limited to:
• Novel disease-modifying targets or strategies for Alzheimer's disease and Parkinson's disease;
• The high-quality clinical trials on AD or PD progression biomarkers, including neuroimaging, electrophysiology, CSF/serum components, risk genes, clinical features, etc;
• The high-quality clinical trials on AD or PD modifying strategies, including drugs or non-pharmacological interventions;
• Highly sensitive and specific predictors or methods for the prognosis of AD or PD;
• Developing the methods of systematic evaluate the effects of drugs and non-pharmacological interventions for postponing the development of AD or PD diseases;
• Exploring the pathogenesis and pathological features of AD or PD diseases progression, such as genetics, epigenetics, neuro-immunity, metabolism, etc.

Keywords: disease-modifying therapies, etiological treatment, biomarker, Parkinson's disease, Alzheimer's disease

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

     

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

     

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

     

Impact

  • 24kTopic views
  • 16kArticle views
  • 6,943Article downloads
View impact